ELIADES GEORGE CHRISTOPHER reported 2 transactions at OYSTER POINT PHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/4/2023ACC: 0001209191-23-001065
Director
Since Apr 2021
-39.18K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
39.18K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−11.76K
Price / share
—
Trade value
—
% of position
41.1%
1/3/2023
28.62K→16.86K
Common Stock
Direct
Shares
−16.86K
Price / share
—
Trade value
—
% of position
New position
1/3/2023
16.86K→0.00
Total
Net shares
−28.62K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2023 | D · Disposition | −11.76K | — | — | 41.1% | 28.62K | 16.86K |
| Common Stock Direct | 1/3/2023 | D · Disposition | −16.86K | — | — | New position | 16.86K | 0.00 |
| Total | −28.62K | $0.00 | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
5.36K shares
Shares
−5.36K
Strike price
3.63
Held after
0.00
Exercisable
—
1/3/2023
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
5.20K shares
Shares
−5.20K
Strike price
17.74
Held after
0.00
Exercisable
—
1/3/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock5.36K shares | 1/3/2023 | D · Disposition | −5.36K | 3.63 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock5.20K shares | 1/3/2023 | D · Disposition | −5.20K | 17.74 | — | 0.00 |